1. Statin initiation was associated with lower mortality and major cardiovascular disease risk in adults with type 2 diabetes across all baseline risk categories.

2. Absolute risk reductions increased with higher baseline cardiovascular risk.

3. Lower-risk patients benefited mainly when low-density or non–high-density lipoprotein cholesterol levels were elevated.

4. No increase in liver dysfunction was observed, and myopathy rates were low.

5. Findings were based on observational UK primary care data and may have limited generalizability.

Source: Annals of Internal Medicine